- Home
- RVMD vs ASND Comparison
RVMD vs ASND Comparison
Compare RVMD & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVMD
- ASND
- Stock Information
- Founded
- RVMD 2014
- ASND 2006
- Country
- RVMD United States
- ASND Denmark
- Employees
- RVMD N/A
- ASND N/A
- Industry
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- RVMD Health Care
- ASND Health Care
- Exchange
- RVMD Nasdaq
- ASND Nasdaq
- Market Cap
- RVMD 7.5B
- ASND 10.6B
- IPO Year
- RVMD 2020
- ASND 2015
- Fundamental
- Price
- RVMD $37.87
- ASND $174.18
- Analyst Decision
- RVMD Strong Buy
- ASND Strong Buy
- Analyst Count
- RVMD 12
- ASND 17
- Target Price
- RVMD $68.67
- ASND $220.06
- AVG Volume (30 Days)
- RVMD 3.1M
- ASND 399.8K
- Earning Date
- RVMD 08-06-2025
- ASND 09-02-2025
- Dividend Yield
- RVMD N/A
- ASND N/A
- EPS Growth
- RVMD N/A
- ASND N/A
- EPS
- RVMD N/A
- ASND N/A
- Revenue
- RVMD N/A
- ASND $398,509,511.00
- Revenue This Year
- RVMD N/A
- ASND $75.05
- Revenue Next Year
- RVMD $241.39
- ASND $78.14
- P/E Ratio
- RVMD N/A
- ASND N/A
- Revenue Growth
- RVMD N/A
- ASND 12.06
- 52 Week Low
- RVMD $29.17
- ASND $111.09
- 52 Week High
- RVMD $62.40
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- RVMD 44.16
- ASND 55.04
- Support Level
- RVMD $36.65
- ASND $167.52
- Resistance Level
- RVMD $38.18
- ASND $180.78
- Average True Range (ATR)
- RVMD 1.53
- ASND 5.72
- MACD
- RVMD -0.31
- ASND -0.62
- Stochastic Oscillator
- RVMD 29.10
- ASND 52.65
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.